BRACAnalysis® By The Numbers

One Million Patients who have benefitted from Myriad Genetic’s BRACAnalysis test
250,000 BRACAnalysis tests conducted each year
$500,000,000 Myriad’s investment in BRACAnalysis
18,000 Number of scientists who have studied the BRCA1 and BRCA2 genes
10,000 Number of scientific papers published on the BRCA1 and BRCA2 genes
$100 Average out-of-pocket expense for BRACAnalysis
95 percent Patients in the U.S. have access to BRACAnalysis testing through private insurance or other coverage
> 5,000 Number of women who have benefited from Myriad’s patient assistance program in the last three years

About Myriad Genetics